DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Yi BA, Freedholm D, Widener N. et al.
Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa.
J Thromb Haemost 2022;
20 (02) 307-315
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.